Skip to main content
Clinical Trials/JPRN-UMIN000031308
JPRN-UMIN000031308
Recruiting
未知

Pilot study of ketogenic diet adjunctive to standard therapy for malignant glioma. - Ketogenic diet therapy for malignant glioma.

Kobe University Hospital0 sites10 target enrollmentApril 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
malignant glioma
Sponsor
Kobe University Hospital
Enrollment
10
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2018
End Date
March 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Age \<20\-year\-old 2\. Gastrointestinal obstruction or ileus 3\. HbA1c \> 6\.1 %, or medication of DM 4\. Inability of ketone body production from fatty acid 5\. Genetic disorders of fat metabolism (Organic cation transporter 2 (OCTN2\) deficiency, Carnitine palmitoyl transferase I or II deficiency, Carnitine palmitoyl transferase II deficiency, beta\-oxidation enzyme deficiency, Medium\-chain acyl\-CoA dehydrogenase (MCAD) deficiency, Long\-chain acyl\-CoA dehydrogenase (MCAD) deficiency, Short\-chain acyl\-CoA dehydrogenase (MCAD) deficiency, 3\-hydroxy acyl\-CoA dehydrogenase (HADH) deficiency, Pyruvate carboxylase deficiency) 6\. Heart failure (NYHA \>2\), acute myocardil infarction (\<\=6 months), atrial fibrillation 7\. Systemic infection 8\. Enrolled in another treatment trial 9\. Inability or unwillingness of subject to give written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials